Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-02-01
2011-02-01
Romeo, David S (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S098000
Reexamination Certificate
active
07879561
ABSTRACT:
The invention is a method of detecting CAD in a CKD diagnosed human patient or CKD in a diagnosed CAD patient, or detection the presence of both CDK and CAD by assaying a plasma or serum sample of a human patient for elevated levels of BMP-4.
REFERENCES:
patent: 6723698 (2004-04-01), Rueger et al.
patent: 2002/0173453 (2002-11-01), Akella et al.
patent: 2006/0014278 (2006-01-01), Khillan et al.
Griethe et al. Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis. J Nephrol. Sep.-Oct. 2003;16(5):728-32.
International Search and Written Opinion report issued on May 21, 2008 by the United States Patent Office as International Search Authority on PCT/US07/81259.
International Preliminary Report on Patentability issued on Apr. 23, 2009 by the International Bureau of WIPO on PCT/US07/81259.
Goldman Corey Keith
Woods Thomas Cooper
Jones, Walker, Waechter Poitevent, Carrere, & Denegre, L.L.
Ochsner Clinic Foundation
Romeo David S
LandOfFree
Detection of chronic kidney disease patients or coronary... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of chronic kidney disease patients or coronary..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of chronic kidney disease patients or coronary... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2623813